The Board of Directors of Emami Limited, has approved the proposal to Buyback Equity Shares of the Company upto Rs. 450 per share through open market purchase.
Natco Pharma Limited announced via an exchange filing, that the Board of Directors of the company at its meeting held on 8th March, 2023 has inter alia:
1. Approved a proposal to buyback by the Company of up to 30,00,000 fully paid-up equity shares of face value of Rs 2 each at a price not exceeding Rs 700 per Equity Share payable in cash for an aggregate amount not exceeding 210,00,00,000